155 related articles for article (PubMed ID: 1370753)
1. CD5 expression in B-cell small lymphocytic malignancies. Correlations with clinical presentation and sites of disease.
Sundeen JT; Longo DL; Jaffe ES
Am J Surg Pathol; 1992 Feb; 16(2):130-7. PubMed ID: 1370753
[TBL] [Abstract][Full Text] [Related]
2. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
3. Multiple lymphomatous polyposis of the gastrointestinal tract. An extensive histopathologic and immunohistochemical study of 12 cases.
Lavergne A; Brouland JP; Launay E; Nemeth J; Ruskone-Fourmestraux A; Galian A
Cancer; 1994 Dec; 74(11):3042-50. PubMed ID: 7954267
[TBL] [Abstract][Full Text] [Related]
4. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features.
Zukerberg LR; Medeiros LJ; Ferry JA; Harris NL
Am J Clin Pathol; 1993 Oct; 100(4):373-85. PubMed ID: 8213632
[TBL] [Abstract][Full Text] [Related]
5. The utility of CD20 and CD43 in subclassification of low-grade B-cell lymphoma on paraffin sections.
Contos MJ; Kornstein MJ; Innes DJ; Ben-Ezra J
Mod Pathol; 1992 Nov; 5(6):631-3. PubMed ID: 1285443
[TBL] [Abstract][Full Text] [Related]
6. CD5+ low-grade marginal zone B-cell lymphomas with localized presentation.
Ballesteros E; Osborne BM; Matsushima AY
Am J Surg Pathol; 1998 Feb; 22(2):201-7. PubMed ID: 9500221
[TBL] [Abstract][Full Text] [Related]
7. Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations.
Lardelli P; Bookman MA; Sundeen J; Longo DL; Jaffe ES
Am J Surg Pathol; 1990 Aug; 14(8):752-63. PubMed ID: 2198813
[TBL] [Abstract][Full Text] [Related]
8. CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia.
Huang JC; Finn WG; Goolsby CL; Variakojis D; Peterson LC
Am J Clin Pathol; 1999 Jan; 111(1):123-30. PubMed ID: 9894463
[TBL] [Abstract][Full Text] [Related]
9. Intravascular large B-cell lymphoma: the CD5 antigen is expressed by a subset of cases.
Khalidi HS; Brynes RK; Browne P; Koo CH; Battifora H; Medeiros LJ
Mod Pathol; 1998 Oct; 11(10):983-8. PubMed ID: 9796727
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections.
Dorfman DM; Shahsafaei A
Mod Pathol; 1997 Sep; 10(9):859-63. PubMed ID: 9310947
[TBL] [Abstract][Full Text] [Related]
11. CD5+ extranodal marginal zone B-cell (MALT) lymphoma. A low grade neoplasm with a propensity for bone marrow involvement and relapse.
Ferry JA; Yang WI; Zukerberg LR; Wotherspoon AC; Arnold A; Harris NL
Am J Clin Pathol; 1996 Jan; 105(1):31-7. PubMed ID: 8561085
[TBL] [Abstract][Full Text] [Related]
12. CD5-expressing B-cell lymphomas/leukemias: relatively high frequency of CD5+ B-cell lymphomas with an overall poor prognosis in Nagasaki Japan.
Kamihira S; Hirakata Y; Atogami S; Sohda H; Tsuruda K; Yamada Y; Tomonaga M
Leuk Lymphoma; 1996 Jun; 22(1-2):137-42. PubMed ID: 8724541
[TBL] [Abstract][Full Text] [Related]
13. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type.
Ott G; Katzenberger T; Greiner A; Kalla J; Rosenwald A; Heinrich U; Ott MM; Müller-Hermelink HK
Cancer Res; 1997 Sep; 57(18):3944-8. PubMed ID: 9307277
[TBL] [Abstract][Full Text] [Related]
14. CD5+ leukemic monocytoid B-cell lymphoma and lymphocytic lymphomas.
Adami F; Semenzato G; Menestrina F; Chilosi M
Am J Clin Pathol; 1993 Aug; 100(2):187-8. PubMed ID: 7689294
[No Abstract] [Full Text] [Related]
15. B-zone small lymphocytic lymphoma: a morphologic, immunophenotypic, and clinical study with comparison to "well-differentiated" lymphocytic disorders.
Carbone A; Pinto A; Gloghini A; Volpe R; Zagonel V
Hum Pathol; 1992 Apr; 23(4):438-48. PubMed ID: 1563746
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity?
Berger F; Traverse-Glehen A; Felman P; Callet-Bauchu E; Baseggio L; Gazzo S; Thieblemont C; Ffrench M; Magaud JP; Salles G; Coiffer B
Clin Lymphoma; 2005 Mar; 5(4):220-4. PubMed ID: 15794852
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic evaluation of the bone marrow in non-Hodgkin's lymphoma.
Fineberg S; Marsh E; Alfonso F; Espiritu E; Gottesman SR; Amorosi E; Feiner HD
Hum Pathol; 1993 Jun; 24(6):636-42. PubMed ID: 8505041
[TBL] [Abstract][Full Text] [Related]
18. Expression of the activation antigen, 4F2, by non-Hodgkin's lymphomas of B-cell phenotype.
Lewandrowski KB; Medeiros LJ; Harris NL
Cancer; 1990 Sep; 66(6):1158-64. PubMed ID: 1698116
[TBL] [Abstract][Full Text] [Related]
19. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
20. CD43 expression in B cell lymphoma.
Treasure J; Lane A; Jones DB; Wright DH
J Clin Pathol; 1992 Nov; 45(11):1018-22. PubMed ID: 1280654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
